89 related articles for article (PubMed ID: 1334394)
1. [Vaccination against measles at 6 months of age].
Kourouma K; Konde MK; Diallo MP; Conde M; Salomon H; Roussey M; Senecal J
Ann Pediatr (Paris); 1992 Nov; 39(9):566-71. PubMed ID: 1334394
[TBL] [Abstract][Full Text] [Related]
2. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
3. Vaccines and immunization schedules.
Nagel J
Trop Geogr Med; 1985 Sep; 37(3):S42-9. PubMed ID: 2866613
[TBL] [Abstract][Full Text] [Related]
4. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
5. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
6. The role of herd immunity in control of measles.
Black FL
Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.
Okada K; Ueda K; Morokuma K; Kino Y; Tokugawa K; Nishima S
Jpn J Infect Dis; 2004 Apr; 57(2):67-71. PubMed ID: 15118214
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
Rogers S; Sanders RC; Alpers MP
J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
[TBL] [Abstract][Full Text] [Related]
9. [Age-related loss of maternal antibodies against measles in children in La Plata].
del Buono MB; Vaschetti P; Iannicelli J; Silber R
Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
[TBL] [Abstract][Full Text] [Related]
10. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
11. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.
MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS
Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016
[TBL] [Abstract][Full Text] [Related]
12. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
Harry TO; Ogunmekan DA
Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
[TBL] [Abstract][Full Text] [Related]
13. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
14. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P
Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776
[TBL] [Abstract][Full Text] [Related]
15. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
16. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
[TBL] [Abstract][Full Text] [Related]
17. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of vaccination against measles at nine months of age (report of an epidemic).
Ceyhan M; Kanra G; Vargel S; Işikçelik Y
Turk J Pediatr; 1992; 34(3):127-33. PubMed ID: 1485379
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
20. Appropriate age for measles vaccination in the United States.
Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
